Clinical Research Directory

Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study

Sponsor: Nanoscope Therapeutics Inc.

Summary

This study will be conducted following Good Clinical Practice (GCP) and International Conference on Harmonization (ICH) guidelines. Eligible subjects will be consented to return for scheduled study visits for this study following their completion in study NTXMCO-002 (RESTORE). They will not receive a second treatment with MCO-010 (or a repeated sham injection) in this study

Official title: Long Term Follow-up for Subjects Who Previously Participated in the NTXMCO-002 RESTORE Study

Key Details

Conditions

Interventions

Locations (6)